文献速递慢性肾脏病水电解质与酸碱

晚期慢性肾脏病老年患者CKD-MBD生物标志物与症状负担的关联:EQUAL研究结果

Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease: Results from the EQUAL Study.
PubMed 文献 · Clin J Am Soc Nephrol · 2024-07-22

本研究基于欧洲EQUAL队列中1396例≥65岁、eGFR≤20 ml/min/1.73 m²的非透析晚期CKD患者,随访至5年,采用广义线性混合效应模型分析重复测量的PTH、磷、钙与总体症状数目(0–33)、严重度(0–165)及33种CKD相关症状的关联。结果显示PTH与症状负担呈U形关联,轻至中度PTH升高者症状负担较低;

要点

  • 非透析晚期CKD老年患者中,轻至中度PTH升高与较低症状负担相关,但效应量较小。
  • 血磷和血钙与总体症状负担无独立关联,仅严重高磷合并严重甲旁亢时症状增多。
  • 评估症状负担时需关注CKD-MBD生物标志物的联合效应而非单一指标。

核心结论

  • 在非透析晚期CKD老年患者中,轻至中度升高的PTH与较低症状负担相关,但效应量较小(不足一个症状)。
  • 血磷和血钙与总体症状负担无独立关联,但严重高磷血症合并严重甲状旁腺功能亢进时症状数目增加。

研究设计与样本

  • 基于欧洲EQUAL研究,纳入6个欧洲国家≥65岁、eGFR≤20 ml/min/1.73 m²的非透析CKD患者,随访至5年。
  • 共纳入1396例患者,采用广义线性混合效应模型分析重复测量的PTH、磷、钙与症状负担的关联。

主要发现

  • 基线时患者平均有13±6个症状,总体严重度评分中位数为32(四分位距19–50)。
  • PTH水平与症状负担呈U形关联,轻至中度PTH升高者症状负担较低。
  • 血磷和血钙与总体症状负担无独立关联。
  • 低钙血症和高磷血症与症状负担的关联似乎因性别和年龄而异。

临床怎么用

  • 对非透析晚期CKD老年患者,轻至中度PTH升高可能不提示更高的症状负担,避免仅凭PTH轻度升高过度干预。
  • 关注严重高磷血症合并严重甲状旁腺功能亢进的患者,其症状负担最高,可能需优先管理。
  • 血磷和血钙单独与总体症状负担无关,症状评估应综合考虑CKD-MBD标志物的联合效应。

局限性

  • 研究为观察性设计,无法确定因果关系。
  • PTH与症状负担关联的效应量较小(不足一个症状),临床意义有限。
  • 低钙血症和高磷血症与症状负担的关联因性别和年龄而异,需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: In nondialysis patients with advanced CKD, mild-to-moderately increased parathyroid hormone is associated with lower levels of reported symptoms. Phosphate and calcium are not independently associated with overall symptom burden. Patients with both severe hyperphosphatemia and severe hyperparathyroidism had the highest symptom burden. BACKGROUND: Patients with advanced CKD develop numerous symptoms, with a multifactorial origin. Evidence linking mineral disorders (CKD-Mineral and Bone Disorder) and uremic symptoms is scant and mostly limited to dialysis patients. Here, we aim to assess the association between CKD-Mineral and Bone Disorder and symptom burden in nondialysis patients with CKD. METHODS: We used data from the European Quality study, which includes patients aged ≥65 years with eGFR ≤20 ml/min per 1.73 m2 from six European countries, followed up to 5 years. We used generalized linear mixed-effect models to determine the association between repeated measurements of parathyroid hormone (PTH), phosphate, and calcium with the overall symptom number (0–33), the overall symptom severity (0–165), and the presence of 33 CKD-related symptoms. We also analyzed subgroups by sex, age, and diabetes mellitus and assessed effect mediation and joint effects between mineral biomarkers. RESULTS: The 1396 patients included in the study had a mean of 13±6 symptoms at baseline, with a median overall severity score of 32 (interquartile range, 19–50). The association between PTH levels and symptom burden appeared U-shaped with a lower symptom burden found for mild-to-moderately increased PTH levels. Phosphate and calcium were not independently associated with overall symptom burden. The highest symptom burden was found in patients with a combination of both severe hyperparathyroidism and severe hyperphosphatemia (+2.44 symptoms [0.50–4.38], P = 0.01). The association of both hypocalcemia and hyperphosphatemia with symptom burden seemed to differ by sex and age. CONCLUSIONS: In older patients with advanced CKD not on dialysis, mild-to-moderately increased PTH was associated with a lower symptom burden, although the effect size was relatively small (less than one symptom). Neither phosphate nor calcium were associated with the overall symptom burden, except for the combination of severe hyperphosphatemia and severe hyperparathyroidism which was associated with an increased number of symptoms.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Magagnoli L, Cozzolino M, Evans M, et al. Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease: Results from the EQUAL Study. Clin J Am Soc Nephrol. 2024. PMID: 39037951. doi:10.2215/CJN.0000000000000510

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。